Alex Aravanis, Illumina chief technology officer

Il­lu­mi­na and Deer­field link arms to dri­ve 'ge­nomics-first' drug dis­cov­ery

Af­ter years of part­ner­ing with the phar­ma in­dus­try, Il­lu­mi­na is now mak­ing its own for­ay in­to drug dis­cov­ery. The DNA se­quenc­ing com­pa­ny is en­ter­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.